Genetics and Markers of Degenerative and Inflammatory Eye Diseases
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Diabetic Retinopathy
Related studies linked through entity extraction aliases.
Pharmacological Intervention in Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- NA
Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study
- Status
- COMPLETED
- Phase
- PHASE3
Preoperative Bevacizumab for Vitreous Hemorrhage
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)
- Status
- COMPLETED
- Phase
- PHASE3
A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging
- Status
- COMPLETED
- Phase
- N/A
Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE3
Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic Patients
- Status
- UNKNOWN
- Phase
- NA
Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Refractory Diabetic Macular Edema With Infliximab
- Status
- TERMINATED
- Phase
- PHASE3
Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training
- Status
- COMPLETED
- Phase
- NA
Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program
- Status
- UNKNOWN
- Phase
- N/A
Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE4
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)
- Status
- WITHDRAWN
- Phase
- PHASE2
Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
The Course of Response to Focal Photocoagulation for DME
- Status
- COMPLETED
- Phase
- N/A